Device Trial Radar · NCT00669032
Efficacy and Safety of Repeated Intraarticular Injections of Hyaluronic Acid in Patients With OA of the Knee
Last checked: Nov 20, 2026Latest source record: Aug 28, 2023 (this record)Source: ClinicalTrials.govMethods & limitations
Sponsor
- Lead sponsor
- Tedec-Meiji Farma, S.A.Not on our public-company list
- Sponsor type
- Industry
- First posted
- Apr 29, 2008
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 45 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The main objective is the long-term comparison (3 years and 4 months) of the efficacy and safety of repeated intra-articular administration of hyaluronic acid in the treatment of osteoarthritis of the knee.
Conditions
- Osteoarthritis of the Knee
Interventions
Hyaluronic acidDevice
3 cycles of 5 hyaluronic acid injections, with a 6 month interval between each one. A 4th treatment cycle of five injections will be carried out at the end of one year
PlaceboOther
3 cycles of 5 saline solution injections, with a 6 month interval between each one. A 4th treatment cycle of five injections will be carried out at the end of one year
Primary outcomes
What the sponsor says the trial is designed to measure.
- Responders OARSI 2004 at the End of Follow-upTime frame: 40 months
Locations
No sites are listed on the registry yet.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.